HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
NEK8
NIMA related kinase 8
Chromosome 17 Β· 17q11.2
NCBI Gene: 284086Ensembl: ENSG00000160602.15HGNC: HGNC:13387UniProt: Q86SG6
40PubMed Papers
23Diseases
0Drugs
38Pathogenic Variants
FUNCTIONAL ROLE
Kinase
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
animal organ morphogenesisregulation of hippo signalingprotein bindingciliumrenal-hepatic-pancreatic dysplasia 2nephronophthisis 9nephronophthisisrenal-hepatic-pancreatic dysplasia
✦AI Summary

NEK8 is a serine/threonine kinase essential for renal tubular integrity and ciliary function 1. It localizes to cilia as part of the INV complex alongside inversin, ANKS6, and NPHP3, where it regulates ciliary protein trafficking and biogenesis 21. NEK8 plays critical roles in left-right determination and organ development, including kidney, heart, and liver 1, and regulates Hippo signaling pathway components 3. Biallelic NEK8 mutations cause syndromic ciliopathies including nephronophthisis-9 and renal-hepatic-pancreatic dysplasia-2 1. Recently, heterozygous missense variants in the kinase domain (p.Arg45Trp, p.Lys157Gln) were identified as a novel autosomal dominant cause of polycystic kidney disease, exhibiting dominant-negative effects 2. These variants impair polycystin-2 ciliary localization and reduce kinase activity, triggering increased DNA damage signaling 2. Beyond renal disease, NEK8 contributes to gastric cancer progression through asparagine metabolism reprogramming and mTORC1 pathway activation 4, and appears in childhood cardiomyopathy genetics 3. However, NEK8 pathogenic variants show no ocular manifestations despite causing systemic ciliopathies 5. The precise kinase substrates and regulatory mechanisms remain incompletely understood 1.

Sources cited
1
Heterozygous NEK8 kinase domain variants cause autosomal dominant polycystic kidney disease through dominant-negative effects, impairing polycystin-2 ciliary localization and kinase activity, with increased DNA damage signaling
PMID: 37598857
2
NEK8 is a NIMA-family serine/threonine kinase localizing to cilia as part of the INV complex with inversin, ANKS6, and NPHP3; essential for left-right determination and kidney/heart/liver development; substrate and regulation mechanisms remain elusive
PMID: 40189576
3
NEK8 promotes gastric cancer progression by phosphorylating ASNS at S349, stabilizing asparagine synthase and activating mTORC1 signaling through asparagine metabolism reprogramming
PMID: 39762761
4
NEK8 implicated in childhood dilated cardiomyopathy as a developmental disease gene in severe early-onset heart disease
PMID: 30384889
5
NEK8 pathogenic variants in renal ciliopathies show no reported ocular manifestations, with low retinal expression and no ocular features in mouse models
PMID: 37644229
Disease Associationsβ“˜23
renal-hepatic-pancreatic dysplasia 2Open Targets
0.75Strong
nephronophthisis 9Open Targets
0.71Strong
nephronophthisisOpen Targets
0.69Moderate
renal-hepatic-pancreatic dysplasiaOpen Targets
0.63Moderate
polycystic kidney disease 8Open Targets
0.54Moderate
Autosomal dominant polycystic kidney diseaseOpen Targets
0.47Moderate
genetic disorderOpen Targets
0.42Moderate
nephronophthisis 2Open Targets
0.38Weak
Polycystic Kidney DiseaseOpen Targets
0.37Weak
familial cystic renal diseaseOpen Targets
0.37Weak
Infantile nephronophthisisOpen Targets
0.37Weak
neuroinflammatory disorderOpen Targets
0.34Weak
neurodegenerative diseaseOpen Targets
0.22Weak
kidney diseaseOpen Targets
0.15Weak
kidney failureOpen Targets
0.15Weak
Premature ovarian insufficiencyOpen Targets
0.14Weak
Varicose veinsOpen Targets
0.13Weak
gastric cancerOpen Targets
0.08Suggestive
breast cancerOpen Targets
0.08Suggestive
focal segmental glomerulosclerosisOpen Targets
0.08Suggestive
Nephronophthisis 9UniProt
Polycystic kidney disease 8UniProt
Renal-hepatic-pancreatic dysplasia 2UniProt
Pathogenic Variants38
NM_178170.3(NEK8):c.1495C>T (p.Arg499Ter)Pathogenic
Renal-hepatic-pancreatic dysplasia 2;Nephronophthisis 9;Polycystic kidney disease 8|Renal-hepatic-pancreatic dysplasia 2
β˜…β˜…β˜†β˜†2025β†’ Residue 499
NM_178170.3(NEK8):c.379C>T (p.Arg127Ter)Pathogenic
Renal-hepatic-pancreatic dysplasia 2|Nephronophthisis 9|Nephronophthisis 9;Renal-hepatic-pancreatic dysplasia 2;Polycystic kidney disease 8
β˜…β˜…β˜†β˜†2025β†’ Residue 127
NM_178170.3(NEK8):c.211del (p.Leu71fs)Likely pathogenic
not provided
β˜…β˜…β˜†β˜†2024β†’ Residue 71
NM_178170.3(NEK8):c.1418-1G>APathogenic
Nephronophthisis 9;Renal-hepatic-pancreatic dysplasia 2|Nephronophthisis 9
β˜…β˜…β˜†β˜†2024
NM_178170.3(NEK8):c.889+1G>TLikely pathogenic
Nephronophthisis 9|Renal-hepatic-pancreatic dysplasia 2;Polycystic kidney disease 8;Nephronophthisis 9
β˜…β˜…β˜†β˜†2024
NM_178170.3(NEK8):c.1795C>T (p.Arg599Ter)Pathogenic
Renal-hepatic-pancreatic dysplasia 2|Premature ovarian insufficiency|not provided|Renal-hepatic-pancreatic dysplasia 2;Nephronophthisis 9|NEK8-related disorder|Nephronophthisis 9
β˜…β˜…β˜†β˜†2024β†’ Residue 599
NM_178170.3(NEK8):c.1401G>A (p.Trp467Ter)Pathogenic
not provided|Renal-hepatic-pancreatic dysplasia 2
β˜…β˜…β˜†β˜†2023β†’ Residue 467
NM_178170.3(NEK8):c.1330G>T (p.Glu444Ter)Pathogenic
Nephronophthisis 9|Renal-hepatic-pancreatic dysplasia 2
β˜…β˜…β˜†β˜†2023β†’ Residue 444
NM_178170.3(NEK8):c.1359_1360del (p.His454fs)Pathogenic
Nephronophthisis 9|Nephronophthisis 9;Renal-hepatic-pancreatic dysplasia 2
β˜…β˜…β˜†β˜†2021β†’ Residue 454
NM_178170.3(NEK8):c.882_885del (p.Cys295fs)Pathogenic
Nephronophthisis 9
β˜…β˜†β˜†β˜†2025β†’ Residue 295
NM_178170.3(NEK8):c.1395del (p.Phe465fs)Pathogenic
Nephronophthisis 9
β˜…β˜†β˜†β˜†2025β†’ Residue 465
NM_178170.3(NEK8):c.67C>T (p.Arg23Ter)Pathogenic
Inborn genetic diseases
β˜…β˜†β˜†β˜†2025β†’ Residue 23
NM_178170.3(NEK8):c.828-1G>CLikely pathogenic
Nephronophthisis 9
β˜…β˜†β˜†β˜†2024
NM_178170.3(NEK8):c.1189dup (p.Ala397fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 397
NM_178170.3(NEK8):c.1224_1227delLikely pathogenic
Renal-hepatic-pancreatic dysplasia 2;Nephronophthisis 9;Polycystic kidney disease 8
β˜…β˜†β˜†β˜†2024
NM_178170.3(NEK8):c.763C>T (p.Gln255Ter)Likely pathogenic
Renal-hepatic-pancreatic dysplasia 2;Nephronophthisis 9;Polycystic kidney disease 8
β˜…β˜†β˜†β˜†2024β†’ Residue 255
NM_178170.3(NEK8):c.1910G>A (p.Trp637Ter)Likely pathogenic
Renal-hepatic-pancreatic dysplasia 2;Nephronophthisis 9;Polycystic kidney disease 8
β˜…β˜†β˜†β˜†2024β†’ Residue 637
NM_178170.3(NEK8):c.995_996del (p.Thr332fs)Likely pathogenic
Renal-hepatic-pancreatic dysplasia 2;Nephronophthisis 9;Polycystic kidney disease 8
β˜…β˜†β˜†β˜†2024β†’ Residue 332
NM_178170.3(NEK8):c.1068G>A (p.Trp356Ter)Likely pathogenic
Renal-hepatic-pancreatic dysplasia 2;Nephronophthisis 9;Polycystic kidney disease 8
β˜…β˜†β˜†β˜†2024β†’ Residue 356
NM_178170.3(NEK8):c.1924C>T (p.Arg642Ter)Pathogenic
Nephronophthisis 9
β˜…β˜†β˜†β˜†2024β†’ Residue 642
View on ClinVar β†—
Related Genes
NPHP3Protein interaction95%NPHP4Protein interaction95%ANKS3Protein interaction91%PIK3C2AProtein interaction80%NPHP1Protein interaction75%PKD1Protein interaction75%
Tissue Expression6 tissues
Liver
100%
Lung
70%
Ovary
50%
Bone Marrow
47%
Brain
21%
Heart
19%
Gene Interaction Network
Click a node to explore
NEK8NPHP3NPHP4ANKS3PIK3C2ANPHP1PKD1
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt Q86SG6
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.83LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.66 [0.53–0.83]
RankingsWhere NEK8 stands among ~20K protein-coding genes
  • #10,215of 20,598
    Most Researched40
  • #1,603of 5,498
    Most Pathogenic Variants38
  • #7,159of 17,882
    Most Constrained (LOEUF)0.83
Genes detectedNEK8
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
PMID: 27336129
1.00
2
Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease.
PMID: 37598857
Kidney Int Β· 2023
0.90
3
USP19 potentiates autophagic cell death via inhibiting mTOR pathway through deubiquitinating NEK9 in pancreatic cancer.
PMID: 39627360
Cell Death Differ Β· 2025
0.80
4
Genetic Basis of Severe Childhood-OnsetΒ Cardiomyopathies.
PMID: 30384889
J Am Coll Cardiol Β· 2018
0.70
5
NEK8, a NIMA-family protein kinase at the core of the ciliary INV complex.
PMID: 40189576
Cell Commun Signal Β· 2025
0.60